• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
73,572.33 -671.01
( -0.90%)
Global Indices
Nasdaq
51,098.17 -484.76
(-0.94%)
Dow Jones
7,440.28 -165.03
(-2.17%)
Hang Seng
66,711.59 -759.10
(-1.13%)
Nikkei 225
10,374.30 13.98
(0.13%)
Forex
USD-INR
95.73 0.01
(0.01%)
EUR-INR
111.21 0.07
(0.06%)
GBP-INR
128.58 -0.06
(-0.05%)
JPY-INR
0.60 0.00
(0.01%)

EQUITY - MARKET SCREENER

Silgo Retail Ltd
Industry :  Diamond Cutting / Jewellery
BSE Code
ISIN Demat
Book Value()
535117
INE01II01013
38.6064748
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
SILGO
42.58
244.58
EPS(TTM)
Face Value()
Div & Yield %
1.8
10
0
 

Novartis India standalone net profit declines 13.82% in the March 2026 quarter
May 12,2026
Net profit of Novartis India declined 13.82% to Rs 25.25 crore in the quarter ended March 2026 as against Rs 29.30 crore during the previous quarter ended March 2025. Sales rose 7.95% to Rs 90.55 crore in the quarter ended March 2026 as against Rs 83.88 crore during the previous quarter ended March 2025.

For the full year,net profit declined 7.65% to Rs 93.18 crore in the year ended March 2026 as against Rs 100.90 crore during the previous year ended March 2025. Sales declined 0.54% to Rs 354.33 crore in the year ended March 2026 as against Rs 356.27 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales90.5583.88 8 354.33356.27 -1
OPM %22.7728.51 -26.5625.66 -
PBDT30.5634.42 -11 131.61132.61 -1
PBT30.1433.89 -11 129.66130.42 -1
NP25.2529.30 -14 93.18100.90 -8